The use of in vitro metabolic parameters and physiologically based pharmacokinetic (PBPK) modeling to explore the risk assessment of trichloroethylene

By Hissink E.M.   Bogaards J.J.P.   Freidig A.P.   Commandeur J.N.M.   Vermeulen N.P.E.   van Bladeren P.J.  

Environmental Toxicology and Pharmacology, Vol. 11, Iss. 3, 2002-07 ,pp. : 259-271

Elsevier

Access to resources Recommend Favorite

Physiologically based pharmacokinetics (PBPK)

By Espié Pascal   Tytgat Dominique   Sargentini-Maier Maria-Laura   Poggesi Italo   Watelet Jean-Baptiste  

Drug Metabolism Reviews, Vol. 41, Iss. 3, 2009-08 ,pp. : 391-407

Informa Healthcare

Access to resources Recommend Favorite

Physiologically Based Pharmacokinetic (PBPK) Models for Nasal Tissue Dosimetry of Organic Esters: Assessing the State-of-Knowledge and Risk Assessment Applications with Methyl Methacrylate and Vinyl Acetate

By Andersen M.E.   Green T.   Frederick C.B.   Bogdanffy M.S.  

Regulatory Toxicology and Pharmacology, Vol. 36, Iss. 3, 2002-12 ,pp. : 234-245

Academic Press

Access to resources Recommend Favorite

Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPK

By  

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 4, 2015-04 ,pp. : 226-230

John Wiley & Sons Inc

Access to resources Recommend Favorite

Monoclonal antibody disposition: a simplified PBPK model and its implications for the derivation and interpretation of classical compartment models

By Fronton Ludivine   Pilari Sabine   Huisinga Wilhelm  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 41, Iss. 2, 2014-04 ,pp. : 87-107

Springer Publishing Company

Access to resources Recommend Favorite